Calcium‐channel blockers: current place in hypertension

Recent NICE guidelines have reaffirmed the place of calcium‐channel blockers as first‐line antihypertensive agents. Our Drug Review considers their properties and place in the management of hypertension, followed by sources of further information, an analysis of prescription data and the Datafile. Copyright © 2007 Wiley Interface Ltd